Novel 4-bp Intronic Deletion (c.1560+3_1560+6del) in LEMD3 in a Korean Patient With Osteopoikilosis.
10.3343/alm.2017.37.6.540
- Author:
In Young YOO
1
;
Ju Sun SONG
;
Chang Seok KI
;
Jong Won KIM
;
Hoon Suk CHA
;
Yong Ki MIN
Author Information
1. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. changski@skku.edu ykmin@skku.edu
- Publication Type:Case Report
- Keywords:
LEMD3;
Osteopoikilosis;
Sequencing;
Deletion
- MeSH:
Bone Morphogenetic Proteins;
Exons;
Fathers;
Humans;
Introns*;
Korea;
Low Back Pain;
Nuclear Envelope;
Osteopoikilosis*;
Sciatica;
Skeleton;
Transforming Growth Factors;
Young Adult
- From:Annals of Laboratory Medicine
2017;37(6):540-543
- CountryRepublic of Korea
- Language:English
-
Abstract:
Osteopoikilosis is an autosomal dominant bone disorder characterized by symmetric multiple osteosclerotic lesions throughout the axial and appendicular skeleton. Pathogenic variants in the LEMD3 have been identified as the cause of osteopoikilosis. LEMD3 encodes an inner nuclear membrane protein that interacts with bone morphogenetic protein (BMP) and transforming growth factor (TGF)-β pathways. We report the case of a 19-year-old man presenting with lower back pain and sciatica. His radiograph revealed bilateral and symmetrical multiple osteosclerotic bone lesions in both scapular areas. Sanger sequencing of LEMD3 revealed a four-base-pair deletion in intron 2 (c.1560+3_1560+6del), which was inherited from his father. We found that this four-base-pair deletion in intron 2 causes aberrant splicing and consequent deletion of exon 2. To the best of our knowledge, this is the first report of genetically confirmed osteopoikilosis in Korea.
